Literature DB >> 15880157

[Assessment of dementia and use of anti-dementia drugs in nursing homes].

Knut Engedal1.   

Abstract

BACKGROUND: About 75% of nursing homes patients in Norway suffer from dementia, though only half of them have a dementia diagnosis. No consensus exists on how or when to do an assessment for dementia in the nursing home.
MATERIAL AND METHODS: The paper is based on a search on Medline and personal experience in the field. RESULTS AND
INTERPRETATION: Dementia assessment in nursing homes should be done in a co-operation between a physician, a nurse and an occupational therapist. The physician should carry out a Mini-Mental State Examination and a clock test, a physical and mental examination, an assessment of depressive symptomatology, and see to it that the thyroid function is measured. A CT scan of the brain should be done in cases with short duration of dementia symptomatology. A nurse and an occupational therapist should interview a family member and assess the patient's functioning by means of the Informant questionnaire on cognitive decline in the elderly and the Clinical dementia rating scale, or a similar assessment tool. Memantine could be a treatment for some patients with moderate to severe degrees of dementia, while acetylcholinesterase inhibitors could be useful for some patients with mild to moderate degrees of dementia of the Alzheimer type. Anti-dementia drug therapy must be individualised.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15880157

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  2 in total

1.  The influence of day care centres designed for people with dementia on family caregivers - a qualitative study.

Authors:  Signe Tretteteig; Solfrid Vatne; Anne Marie Mork Rokstad
Journal:  BMC Geriatr       Date:  2017-01-05       Impact factor: 3.921

2.  End-of-life care communications and shared decision-making in Norwegian nursing homes--experiences and perspectives of patients and relatives.

Authors:  Elisabeth Gjerberg; Lillian Lillemoen; Reidun Førde; Reidar Pedersen
Journal:  BMC Geriatr       Date:  2015-08-19       Impact factor: 3.921

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.